To understand why clinical supervision in pharmacy has not kept pace with professional development, it is necessary to examine where supervision in pharmacy originated, how its meaning has become blurred and why these legacies have produced a persistent gap between contemporary workforce developmental needs and available supervisory structures.

Supervision in pharmacy emerged from legal frameworks designed primarily for public protection rather than professional development. In the UK, the Human Medicines Regulations 2012 [14] defined supervision primarily in terms of ensuring the safe and legal supply of medicines, a regulatory framing that has shaped professional understandings of supervision as a compliance mechanism rather than a developmental one and continues to do so to this day [15]. Many pharmacists still associate supervision with policing of their practice and compliance checking as opposed to learning, reflection or support — a belief which is fundamentally misaligned with contemporary needs for psychological safety and professional dialogue [16, 17].

The introduction of the four pillars of advanced practice added further conceptual complexity [3, 13, 16]. Each pillar incorporates supervision differently, generating a proliferating lexicon of supervisory terms without shared definitions. National guidance on supervision models for pharmacy has reinforced this variation by listing multiple supervision models without providing criteria for their application or defining explicit competencies for the training and quality assurance of clinical supervisors [17], in contrast to established frameworks in other health professions. In medicine, for example, the GMC specifies defined competencies, formal approval processes and quality assurance mechanisms for all clinical supervisors, none of which exist in pharmacy [18, 19]. In increasingly autonomous roles where pharmacists must interpret evidence, manage uncertainty and make high-stakes decisions, this definitional drift creates friction and confusion: when supervision can mean everything, it risks meaning nothing.

Educational theory compounds this ambiguity. Proctor’s model, comprising formative (learning and development), normative (quality assurance and standards) and restorative (emotional support and wellbeing) functions, is widely cited yet rarely experienced in full; evidence from primary care shows the normative component is most frequently absent [20]. Whilst established and effective educational supervision models exist in some pharmacy settings [20, 21], critical gaps remain: clinical supervision is left to employers, undefined; supervision intensity reduces with confidence without reference to capability assurance. No coherent clinical supervision framework has therefore been developed for the profession, a recognised barrier to supporting advanced pharmacy practice [22].

The result is a system in which genuine clinical supervision is often replaced by procedural tools like standard operating procedures that support compliance but not capability. Advanced practice demands far more: pharmacists must navigate uncertainty, balance risks, interpret evidence and tailor decisions to individual contexts through trust, dialogue, and psychologically safe relationships with patients and colleagues [23], consistent with Realistic Medicine’s emphasis on rejecting transactional healthcare and fostering relational, compassionate professional practice [24].

These dynamics expose a clear developmental challenge across two distinct groups of pharmacists: those at early career stages need supervision that builds reflective habits within the safety of guidelines, whilst those entering advanced roles need support to articulate reasoning, manage uncertainty and build confidence in complex decision-making. Across both contexts, the relational, reflective and assurance-focused functions of effective supervision remain unevenly developed, creating a clear need for a coherent model and the shared language to sustain it.